What to Make of The Coca-Cola Company (KO)’s Earnings

Page 1 of 2

The Coca-Cola Company (NYSE:KO)On July 16, giant beverage company The Coca-Cola Company (NYSE:KO) released its quarterly report. It didn’t matter that its earnings-per-share of $0.63 were in line with expectations. It also didn’t matter that second quarter volume grew 1% and year-to-date volume grew 3%. Of no interest was the company’s reported success in penetrating emerging markets like Thailand, Nigeria, and India, where Coke’s brand volume grew by 24%, 15% and 18%, respectively.

All of the above didn’t matter at all. Instead, analysts chose to focus solely on one metric: net revenue. Coke reported that net revenues declined 3% in the second quarter to $12.75 billion, missing analysts’ estimates by $200 million. And that became the talk of the day, sending shares of Coke tumbling by about 2%. To the company’s defense, the company’s CFO Gary Fayard responded that the cold and wet weather was the main cause of this unfortunate revenue miss. Apparently, less dehydrated people mean less need for Coke’s products.

The follies of short-term sight versus long-term wisdom

Earnings season is always a time of increased volatility. Everyone seems to get really excited over a company missing or beating estimates by 1%. This whole “guesstimate” game has turned into a national sport. To get some longer-term focus on the business, let’s turn to the holder of 400 million shares of The Coca-Cola Company (NYSE:KO). That person is Warren Buffett. Coke is the largest stock in Berkshire Hathaway Inc. (NYSE:BRK.A)’s portfolio. In the 2010 letter to shareholders, Buffett discussed Berkshire Hathaway Inc. (NYSE:BRK.A)’s love for The Coca-Cola Company (NYSE:KO) (the company, not the drink…). He stated that,

“Coca-Cola paid us $88 million in 1995, the year after we finished purchasing the stock. Every year since, Coke has increased its dividend. In 2011, we will almost certainly receive $376 million from Coke, up $24 million from last year. Within ten years, I would expect that $376 million to double. By the end of that period, I wouldn’t be surprised to see our share of Coke’s annual earnings exceed 100% of what we paid for the investment. Time is the friend of the wonderful business.”

And that’s precisely what happenedWhen Buffett first bought shares of The Coca-Cola Company (NYSE:KO), it paid less than 8 cents per share annually in dividends, yielding a modest 4%. But since then the company has grown its dividend by an incredible 1,300%, giving Berkshire Hathaway Inc. (NYSE:BRK.A) more than a 50% yield on his original investment today. I will be anything but surprised to see Berkshire, a few more years down the road, earning 100% on its invested capital in The Coca-Cola Company (NYSE:KO) each and every year. These results wouldn’t have been made possible if Buffett had sold out his position whenever The Coca-Cola Company (NYSE:KO) missed on revenues.

Sleep tight, Coca-Cola is behind you

There’s no reason for you to lose sleep of Coke’s revenue miss, and here is why:

  1. Every now and then, you might hear someone say he thinks PepsiCo, Inc. (NYSE:PEP) is a better business than Coke. And after all, Pepsi is always right on Coke’s heels, isn’t it? Well, not really, not from an investor’s point of view anyways. From 2009 to 2011, for every $1 of earnings it retained and reinvested in the business, Pepsi added $2 of market value. For every $1 Coke retained during the same period, Coke added $4 of market value. Another way to look at it is through margins. Whereas Pepsi’s operating margin and profit margin are 14% and 9%, respectively, Coke’s are 23% and 18%. There’s a reason for that. Coke is a better business. It is No. 1. Being the biggest is much more valuable than most investors realize.
Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!